Company intelligence / Profile preview

AllyOncology

United States

Ownership: Private
Development stage: Other

Overview

AllyOncology is a technology-driven group purchasing organization (GPO) serving independent community oncology clinics in the United States. It is focused on optimizing oncology drug management, contracting, and practice economics, rather than developing drugs or therapeutics.[1][3][5]

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

BioCareSDIDEOlogy Health

Beyond the preview

Go deeper on AllyOncology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AllyOncology.

Explore the full profile